UPenn HIV Grand Rounds - Home Page

 

Jointly Sponsored by: Perelman School of Medicine at the University of Pennsylvania, The Penn Cener for AIDS Research and ViralEd, Inc.
 

Live Series Schedule

About the Program

Program Overview

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is live webcast every Thursday at 12:00pm Eastern Time starting in October through June. All webcasts will be available for on-demand viewing immediately following the live broadcast. CME credit will be available for 24 hours following the start of each webcast.

Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hivgrandrounds for easy access. 

Back to Top

Target Audience

This program has been designed for Family Medicine, Pediatrics, Neurology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease

Back to Top

Commercial Support Acknowledgement

HIV Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs,  ViiV Healthcare, Janssen Therapeutics and Merck Sharp and Dohme Corp.

Back to Top

Learning Objectives

After completing this activity, participants should be better able to:

  • Apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients into care
  • Individualize ARV therapy for the treatment-naïve and treatment-experienced patients
  • Manage the aging patient with HIV infection, including issues associated with cardiovascular and bone disease
Back to Top

Course Director

Ian Frank. MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania

Next Session and Participation Information

Presented live at 12:00 PM ET, weekly on Thursdays and anytime On-Demand

  • Delivered via webinar directly to you  and/or your clinic
  • You, or your clinic's coordinator, will receive a weekly email with topic, speaker and webinar link
  • Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device

If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.

Back to Top

Live Session Topics and Speakers


January 17, 2019

The Top Ten Publications in HIV Infection in 2018

Ian Frank, MD

Click HERE to View On-Demand


January 24, 2019

An Innovative Cluster of Studies on the Undiscussed (STIs), the Underfunded (TB) and the Continuing (HIV) Epidemics in South Africa

Andrew Medina-Moreno, MD

Click HERE to View On-Demand


January 31, 2019

Real Cases from the University of Pennsylvania

William Short, MD; Elizabeth Lowenthal, MD; Florence Momplaisir, MD; Richard Rutstein, MD

Click HERE to View On-Demand 


February 7, 2019

Novel Nonhuman Primate Models for HIV Vaccine Development and Cure

Jonah B. Sacha, PhD

Click HERE to View On-Demand 


February 14, 2019

The virtue of simplicity: the vaginal microbiome, genital inflammation, and HIV risk

Douglas Kwon, MD, PhD

Click HERE to View On-Demand 


February 21, 2019

Injecting hope: what the hiv provider should know about the opioid epidemic

Jessica Meisner, MD

Click HERE to View On-Demand 


February 28, 2019

2019 Hepatitis Grand Rounds Overview and Real Cases from the University of Pennsylvania

David Kaplan, MD and Raymond Soccio, MD

Click HERE to View On-Demand


March 14, 2019

Highlights from the 2019 Conference on Retroviruses and Opportunistic Infections (CROI) 

Ian Frank, MD

Click HERE to View On-Demand


March 21, 2019

The Rakai Health Sciences Program: 30 Years of HIV Multidisciplinary Research, Lessons Learned, Future Directions

Larry W. Chang, MD, PhD

Click HERE to View On-Demand


March 28, 2019

Hepatitis C:  Treatment in Primary Care and Resource-limited settings

Shyam Kottilil MD, PhD

Click HERE to View On-Demand


April 4, 2019

Natural Hosts of SIV: What can we learn for HIV Cure?

Michela Muller-Trutwin, PhD


April 11, 2019

Early Data on ‘Treat All’ Guideline Implementation for HIV/AIDS, and Developing Research Priorities to Inform Future Implementation

Denis Nash, PhD

Click HERE to View On-Demand


April 18, 2019

Beyond Hashtags: Using digital epidemiology to advance HIV prevention among youth

Robin Stevens, PhD

Click HERE to View On-Demand


April 25, 2019

Update on the Use of Hepatitis C-infected Organs in Solid Organ Transplantation

David Goldberg, MD

Click HERE to View On-Demand


May 2, 2019

Real Cases from the University of Pennsylvania

Ian Frank, MD

Click HERE to View On-Demand


May 9, 2019

Innovations in mobile technology for engaging youth in HIV treatment and prevention

Lisa Hightow-Weidman, MD, MPH

Click HERE to View On-Demand


May 16, 2019

ID Doctors Treating Infections in People Who Use Drugs: What Is Our Next Move?

Alysse Wurcel, MD, MS

Click HERE to View On-Demand


May 23, 2019

EASL International Liver Congress 2019 Update 

Mark Sulkowski, MD

Click HERE to View On-Demand


May 30, 2019

Parent-Child Sex Communication and Adolescent YMSM: Implications for HIV/STI Prevention and Care

Dalmacio Dennis Flores, PhD, ACRN

Click HERE to View On-Demand


June 6, 2019

Lung Injury in Pulmonary TB: Methods of Assessment and Mediators of Damage

Gregory P Bisson, MD, MSCE

Click HERE to View On-Demand


June 13, 2019

CROI 2019 Update: Viral Hepatitis

Susanna Naggie, MD

Click HERE to View On-Demand


June 20, 2019

PrEP Update: A Million Dreams

Helen Koenig, MD

Click HERE to Register


June 27, 2019

Update on ART (Title TBD)

Ian Frank, MD

Click HERE to Register

 

 
 

Back to Top

Hardware/Software Notice

You will need Internet to participate in this activity.

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credit

Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE), Mila Kostic, CHCP, FACEHP, Director of CME and Co-Director of IPCE Penn Medicine, Zalman Agus, MD, Senior Peer Reviewer and Patricia A. Smith, DNP, RN-BC, Penn IPCE Lead Nurse Planner have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee Members:

  • ViralEd, Inc.: Brian Boyle, MD; Oliver Fultz; Rick Gordon
  • UPenn CME: Mila Kostic, CHCP, FACEHP

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:


Ian Frank, MD (Program Chair)

  • Advisor or Review Panel Member:Gilead; GlaxoSmithKline
  • Grant/Research Support Recipient: Johnson & Johnson
Back to Top

Discussion of Investigational and/or Off-label Use of Commercial Products and Devices

The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

   

    UPenn CME - 2019          VE Logo 2019           CFAR 2019

     



 

 

Back to Top

 


ViralEd, LLC

http://www.viraled.com/modules/info/upenn_hiv_grand_rounds_-_home_page.html